APOE and atherosclerosis: Furthermore, Mas receptor activation with the agonist AVE0991 induced anti-atherosclerotic and anti-inflammatory actions by reducing monocyte/macrophage differentiation and recruitment to PVAT during early stages of atherosclerosis in ApoE−/− mice (Skiba et al., 2017).